Bausch health companies inc. (BHC)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Revenues
Service and other

-

-

-

-

-

-

-

-

35

12

15

26

Total revenues

8,601

8,380

8,724

9,674

10,447

8,206

5,769

3,480

2,427

1,181

820

757

Expenses
Selling, general and administrative

2,554

2,473

2,582

2,810

2,700

2,026

1,305

756

572

276

167

188

Research and Development Expense (Excluding Acquired in Process Cost)

471

413

361

421

334

246

156

79

65

68

47

69

Amortization of Intangible Assets Excluding Amortization Allocated to Revenues Cost of Good Sold

1,897

2,644

2,690

2,673

2,257

1,427

1,902

928

557

219

104

51

Goodwill impairments

0

2,322

312

1,077

0

0

-

-

-

-

-

-

Asset Impairment Charges

75

568

714

422

304

145

-

-

-

-

-

-

Restructuring Charges

31

22

52

132

362

382

462

267

97

140

30

70

Acquired in-process research and development costs

-

-

-

34

106

20

153

189

109

89

59

-

Other expense (income) (Note 16)

-

-

-

-

-

263

-

-

-

-

-

-

Acquisition-related costs

-

-

-

-

-

-

36

78

32

38

5

-

Legal settlements and related fees

-

-

-

-

-

-

-

-

-

-52

-6

-32

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset

-12

9

289

13

23

14

29

5

10

-

-

-

Other Operating Income (Expense), Net

-1,414

20

348

-73

-295

-

-287

-136

6

-

-

-

Total expenses

8,804

10,764

8,622

10,240

8,920

6,205

6,179

3,400

2,127

1,291

639

633

Operating Income (Loss)

-203

-2,384

102

-566

1,527

2,001

-409

79

299

-110

181

124

Interest income

12

11

12

8

4

5

8

6

4

1

1

9

Interest expense

1,612

1,685

1,840

1,836

1,563

971

844

481

334

84

24

1

Write-down of deferred financing charges

-

-

-

-

-

-

-

-

-

5

0

-

Gain (Loss) on Extinguishment of Debt

-42

-119

-122

0

-20

-130

-65

-20

-36

-32

-

-

Foreign exchange and other

8

23

107

-41

-103

-144

-9

19

26

0

0

-1

Gain on investments, net (Note 23)

-

-

-

-

-

293

5

2

22

-5

17

-4

Loss before benefit from income taxes

-1,837

-4,154

-1,741

-2,435

-155

1,054

-1,314

-394

-18

-236

174

126

Income Tax Expense (Benefit)

-54

-10

-4,145

-27

133

174

-450

-278

-177

-28

-1

-73

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-1,783

-4,144

2,404

-2,408

-288

880

-863

-116

159

-

-

199

Net income attributable to noncontrolling interest

5

4

0

1

4

-1

2

0

0

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-1,788

-4,148

2,404

-2,409

-292

881

-866

-116

159

-208

176

-

(Loss) earnings per share attributable to Bausch Health Companies Inc.
Basic (in dollars per share)

-5.08

-11.81

6.86

-6.94

-0.85

2.63

-2.70

-0.38

0.52

-1.06

1.11

1.25

Diluted (in dollars per share)

-5.08

-11.81

6.83

-6.94

-0.85

2.58

-2.70

-0.38

0.49

-1.06

1.11

1.25

Weighted-average common shares
Basic (in shares)

352

351

350

347

342

335

321

305

304

195

158

159

Diluted (in shares)

352

351

351

347

342

341

321

305

326

195

158

159

Cash dividends declared per share (in dollars per share)

-

-

-

-

-

-

-

-

-

1.28

0.64

1.50

Product sales
Revenues

8,489

8,271

8,595

9,536

10,292

8,046

5,640

3,288

2,255

1,133

789

714

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

2,297

2,309

2,506

2,572

2,532

2,178

1,846

905

683

395

204

197

Other revenues
Revenues

112

109

129

138

155

160

129

191

136

35

15

16

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

53

42

42

39

53

58

58

64

12

10

13

23